Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cancer Genomics and Diagnostics
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the genomic landscape of cancer, mutational signatures, intratumor heterogeneity, liquid biopsies, somatic mutations, tumor evolution, cell-free DNA, genomic instability, targeted therapy, and clonal evolution in various cancer types.
99,739
Works
1,782,222
Citations
IDs:OpenAlex
How has Cancer Genomics and Diagnostics's publication output changed over time?
ScholarIQpublication output · 2015–2019
Output grew0% over the shown period — from 1 works in 2015 to 1 in 2019.
1
1
1
201520172019
Who are the most-cited researchers behind Cancer Genomics and Diagnostics?
ScholarIQtop researchers by citations
What are the most-cited papers on Cancer Genomics and Diagnostics?
ScholarIQmost cited works
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, Clemens Mayer, Mirjana Efremova, Dietmar Rieder, Hubert Hackl, Zlatko Trajanoski
Cell Reports. 20175,423 CitationsOPEN ACCESS
A New Initiative on Precision Medicine
Francis S. Collins, Harold Varmus
New England Journal of Medicine. 20155,212 CitationsOPEN ACCESS
A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Nature. 20192,756 CitationsOPEN ACCESS
Where is Cancer Genomics and Diagnostics research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Cancer Genomics and Diagnostics is open access?
ScholarIQopen access share
100%OPEN ACCESS
Gold
33%
Green
33%
Hybrid
0%
Bronze
33%
Closed
0%
Who collaborates most closely around Cancer Genomics and Diagnostics?
ScholarIQco-authorship network
United States
92%
Italy
8%